GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $305.45M | $202.57M | $234.69M | $212.19M | $179.32M | $196.17M |
| Cost of Revenue | $111.05M | $112.56M | $261.44M | $228.80M | $175.30M | $113.39M |
| Gross Profit | $194.40M | $90.01M | $-26.75M | $-16.60M | $4.03M | $82.78M |
| Gross Margin | 63.64% | 44.43% | -11.40% | -7.82% | 2.25% | 42.20% |
| Operating Expenses | $217.61M | $270.60M | $640.90M | $429.55M | $246.02M | $113.20M |
| Operating Income | $-23.21M | $-180.60M | $-667.65M | $-446.15M | $-241.99M | $-30.41M |
| Operating Margin | -7.60% | -89.15% | -284.48% | -210.25% | -134.95% | -15.50% |
| Net Income | $-52.29M | $-175.77M | $-548.98M | $-245.39M | $-241.34M | $-29.70M |
| Net Margin | -17.12% | -86.77% | -233.91% | -115.64% | -134.58% | -15.14% |
| EPS (Basic) | $-1.94 | $-7.23 | $-53.63 | $-74.93 | $-33.16 | $-4.26 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A |